Skeletal Muscle Satellite Cells, Mitochondria, and MicroRNAs: Their Involvement in the Pathogenesis of ALS
- PMID: 27679581
- PMCID: PMC5020084
- DOI: 10.3389/fphys.2016.00403
Skeletal Muscle Satellite Cells, Mitochondria, and MicroRNAs: Their Involvement in the Pathogenesis of ALS
Abstract
Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is a fatal motor neuron disorder. It results in progressive degeneration and death of upper and lower motor neurons, protein aggregation, severe muscle atrophy and respiratory insufficiency. Median survival with ALS is between 2 and 5 years from the onset of symptoms. ALS manifests as either familial ALS (FALS) (~10% of cases) or sporadic ALS (SALS), (~90% of cases). Mutations in the copper/zinc (CuZn) superoxide dismutase (SOD1) gene account for ~20% of FALS cases and the mutant SOD1 mouse model has been used extensively to help understand the ALS pathology. As the precise mechanisms causing ALS are not well understood there is presently no cure. Recent evidence suggests that motor neuron degradation may involve a cell non-autonomous phenomenon involving numerous cell types within various tissues. Skeletal muscle is now considered as an important tissue involved in the pathogenesis of ALS by activating a retrograde signaling cascade that degrades motor neurons. Skeletal muscle heath and function are regulated by numerous factors including satellite cells, mitochondria and microRNAs. Studies demonstrate that in ALS these factors show various levels of dysregulation within the skeletal muscle. This review provides an overview of their dysregulation in various ALS models as well as how they may contribute individually and/or synergistically to the ALS pathogenesis.
Keywords: amyotrophic lateral sclerosis; miRNA; mitochondria; neuromuscular junction; satellite cell; skeletal muscle.
Figures

Similar articles
-
Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.J Neurosci. 2014 Nov 19;34(47):15587-600. doi: 10.1523/JNEUROSCI.2037-14.2014. J Neurosci. 2014. PMID: 25411487 Free PMC article.
-
Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).Exp Neurol. 2016 Mar;277:275-282. doi: 10.1016/j.expneurol.2016.01.008. Epub 2016 Jan 13. Exp Neurol. 2016. PMID: 26775178 Free PMC article.
-
Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice.Hum Mol Genet. 2010 Jun 1;19(11):2284-302. doi: 10.1093/hmg/ddq106. Epub 2010 Mar 10. Hum Mol Genet. 2010. PMID: 20223753 Free PMC article.
-
Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.Lab Invest. 1997 Apr;76(4):441-56. Lab Invest. 1997. PMID: 9111507 Review.
-
SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis.Front Cell Neurosci. 2015 Aug 25;9:336. doi: 10.3389/fncel.2015.00336. eCollection 2015. Front Cell Neurosci. 2015. PMID: 26379505 Free PMC article. Review.
Cited by
-
P2X7 activation enhances skeletal muscle metabolism and regeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis.Brain Pathol. 2020 Mar;30(2):272-282. doi: 10.1111/bpa.12774. Epub 2019 Aug 18. Brain Pathol. 2020. PMID: 31376190 Free PMC article.
-
In Vivo Imaging of Oxidative and Hypoxic Stresses in Mice Model of Amyotrophic Lateral Sclerosis.Methods Mol Biol. 2022;2525:289-294. doi: 10.1007/978-1-0716-2473-9_22. Methods Mol Biol. 2022. PMID: 35836077
-
The Role of Exercise as a Non-pharmacological Therapeutic Approach for Amyotrophic Lateral Sclerosis: Beneficial or Detrimental?Front Neurol. 2019 Jul 17;10:783. doi: 10.3389/fneur.2019.00783. eCollection 2019. Front Neurol. 2019. PMID: 31379732 Free PMC article. Review.
-
Arsenic Stimulates Myoblast Mitochondrial Epidermal Growth Factor Receptor to Impair Myogenesis.Toxicol Sci. 2020 Jul 1;176(1):162-174. doi: 10.1093/toxsci/kfaa031. Toxicol Sci. 2020. PMID: 32159786 Free PMC article.
-
Targeting mitochondrial Ca2+ uptake for the treatment of amyotrophic lateral sclerosis.J Physiol. 2024 Apr;602(8):1519-1549. doi: 10.1113/JP284143. Epub 2023 Nov 27. J Physiol. 2024. PMID: 38010626 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous